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A B S T R A C T
The aim of this study was to evaluate the prevalence of stage III of retinopathy of prematurity (ROP) among newborns
of birth weight <1500 g and gestational age (GA) 32 weeks, and to compare these prevalences during two time periods
(1998–2002 and 2003–2007). The investigation was conducted at the Department of Gynecology and Obstetrics, Univer-
sity Hospital in Rijeka, Croatia. The screening for ROP was performed by an ophthalmologist using a binocular indirect
ophthalmoscope. Over a period of 10 years, there were 28,627 liveborn newborns, with 136 (0.48%) premature newborns
with a birth weights <1500 g and 226 (0.79%) newborns with GA at birth 32 weeks. The proportions of survivors among
newborns with birth weights <1500 g (51.1% vs.70.5%) and among newborns with GA at birth 32 weeks (67.9% vs.
77.0%) were significantly higher in the later period. During the period 2003–2007, the proportion examined for ROP was
higher among newborns with birth weight <1500 g (52.9% vs. 97.1%) and among newborns with GA at birth 32 weeks
(46.5% vs. 96.9%). The prevalence of stage III ROP was significantly lower in 2003–2007 compared to that in 1998–2002
among newborns with birth weight <1500 g (30.6% vs. 14.0%) and newborns with GA at birth  32 weeks (22.4% vs.
8.8%). The prevalence of total ROP among newborns was significantly lower in 2003–2007 compared with 1998–2002.
This decrease in prevalence may be explained by advances in neonatal intensive care unit, increased survival of very low
birth weight infants and carefully timed retinal examinations.
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Introduction
In the last 60 years, the survival of premature babies
has increased, and this has led to increases in the num-
ber of infants with immature retinal vasculature and in
the incidence of severe retinopathy of prematurity
(ROP)1,2. The risk of ROP increases with decreasing ges-
tational age and birth weight. Premature babies have
less vascularized retinas at birth, and the retinal blood
vessels are very sensitive to the variations from hypoxia
to hyperoxia1. Threshold ROP occurs most frequently in
infants with a birth weight of less than 1250 g, and de-
spite treatment, it can progress to tractional retinal
detachment3. Approximately 10% to 15% of these chil-
dren will become blind4.
In the last twenty years in Croatia, ROP has been the
cause of blindness among 3.6% of blind young persons5.
The screening and treatment of ROP is still insufficient
and not routine in many intensive care units in Croatia6.
The aim of this study was to present the results of
early screening and the prevalence of stage III ROP
among preterm newborns over a 10-year period in a geo-
graphically defined population in Croatia.
Patients and Methods
This study was conducted at the Department of Gyne-
cology and Obstetrics, University Hospital in Rijeka,
Croatia, from 1998–2007. We divided the ten-year period
into two periods: Period l (1998–2002) and Period ll
(2003–2007). In this study, we included newborns with a
birth weights <1500 g and gestations 32 weeks.
69
Received for publication May 26, 2011
We evaluated the following outcomes in the two time
periods: the proportion of babies with a birth weight of
<1500 g and a gestation of 32 weeks, the survival (past
six months) of these babies, the proportions examined by
an ophthalmologist, and the prevalence of severe ROP in
surviving babies with a birth weight of <1500 g and a
gestation of 32 weeks.
The first examination was performed 4 to 6 weeks af-
ter birth, and the follow-up examinations were carried
out approximately 2 weeks after every examination or
more frequently depending on the severity of disease.
The examination was performed by an ophthalmolo-
gist, using a binocular indirect ophthalmoscope, after di-
latation of the pupils with tropicamid drops (»Mydria-
ticum stulln« a 5.0 mg, Pharma Stulln), one drop every
15 minutes, 3 times before examination.
Retinopathy of prematurity staging was defined ac-
cording to the International ROP classification7.
Results
There were 28,627 liveborn newborns over 10 years
(14,186 in Period I and 14,441 in Period II). The number
of liveborn babies with birth weight <1500 g, the num-
ber that survived, and the number examined by an oph-
thalmologist are presented for the total period, and sepa-
rately by Period l and Period ll in Table 1.
There were significantly more survivals among new-
borns birth weight <1500 g (c2=10.26; p=0.001) and
more examinations in Period II than in Period I (c2=
46.16; p=0.0001).
The number of liveborn babies with 32 weeks’ gesta-
tion, the number that survived and the number examined
by an ophthalmologist are presented for the total period,
and separately by Period l and Period ll in Table 2.
There were significantly more survivals among new-
borns 32 weeks’ gestation (c2=3.94; p=0.047) and more
examinations in Period II than in Period I (c2=77.34;
p=0.0001).
The prevalences of total ROP and severe ROP among
examined newborns with birth weighs <1500 g are pre-
sented in Table 3.
There were statistically significantly lower rates of
ROP lll (c2=4.80, p=0.028) and total ROP (c2=8.37,
p=0.003) among examined newborns with birth weights
<1500 g in Period II than in Period I.
The prevalence of total ROP and severe ROP among
examined newborns with 32 weeks’ gestation were pre-
sented in Table 4.
There was a statistically significantly lower preva-
lence of ROP lll among examined newborns with 32
weeks’ gestation in Period ll (c2=6.61; p=0.010) than in
Period I.
There was statistically significantly lower prevalence
of total ROP among examined newborns with 32 weeks’
gestation in Period ll (c2=12.20; p=0.0004) (Table 5).
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TABLE 1
NUMBER OF LIVEBORNS WITH BIRTH WEIGHTS <1500 G,
NUMBER THAT SURVIVED, AND NUMBER EXAMINED OVER






























* Among total liveborns in reviewed period
** Among all liveborns with birth weight <1500 g in reviewed
period
*** Among all surviving newborns with birth weight <1500 g in
reviewed period
TABLE 2
NUMBER OF LIVEBORNS WITH 32 WEEKS’ GESTATION,
NUMBER THAT SURVIVED, AND NUMBER EXAMINED OVER






























* Among total liveborns in reviewed period
** Among all liveborns with 32 weeks’ gestation in reviewed
period
*** Among all surviving newborns with 32 weeks’ gestation in
reviewed period
TABLE 3
NUMBER OF ROP III AND TOTAL ROP IN EXAMINED
NEWBORNS WITH BIRTH WEIGHT <1500 G IN THE TOTAL






















[ ] – in brackets: number of examined newborns birth weight
<1500 g in reviewed period
() – in brackets: percentage of examined newborns birth weight
<1500 g in reviewed period
Discussion
Our results revealed that in the reviewed period from
1998 to 2007, the prevalence of total ROP among exam-
ined newborns with birth weights <1500 g was 38.2%,
and that among examined newborns with 32 weeks’
gestation was 30.5%.
Retinopathy of prematurity (ROP) is a major cause of
childhood blindness or visual disabilities8. In the last
twenty years in Croatia, ROP has been the cause of
blindness in 3.6% of blind young persons. The prevalence
of retinopathy of prematurity in newborns with birth
weights <1500 g was 56.5%, and in newborns with gesta-
tional ages 32 weeks, it was 28.9%5,6. In another investi-
gation from Croatia, the incidence of ROP in newborns
with birth weights 2000 g was 12.8%9.
Larsson et al reported a prevalence of ROP of 25% in
Stokholm, Sweden, and Nodgar et al reported a preva-
lence of ROP of 19.2% in Denmark10,11. In the United
Kingdom, the prevalence of ROP was 19.3%12. In Mexico,
the prevalence of ROP of any stage was 22% in high-risk
premature infants. The highest prevalence, 48%, was in
the birthweight 500–1000 g group13. In Brazil, the preva-
lence of ROP was 27.2%. ROP was confirmed in 50% of
infants with weights below 1000 g and 71.5% of new-
borns born at gestational ages of less than 28 weeks14.
ROP is a leading cause of childhood blindness and visual
disability in the United States. It affects more than 80%
of babies born with birth weights less than 1000 g. The
prevalence of ROP was 20% in newborns with birth
weights 1500 g and 33% in newborns with birth weights
1000 g8,15.
All of these results should be interpreted with caution
due to the studies’ different methodologies, inclusion or
exclusion criteria and relative subjectivity in ROP stag-
ing. Wallace et al reported a pilot study using a special
fully-automated computer program that identified and
measured dilation and tortuosity of retinal blood vessels
(»ROPtool«). It can reduce the subjectivity and improve
the accuracy in assessing the presence of disease16.
According to the Recommendations for Screening ex-
amination of premature infants for ROP, infants with a
birth weight of less than 1500 g or a gestational age of 32
weeks or less should have a first retinal screening exami-
nation 4 to 6 weeks after birth by an ophthalmologist us-
ing a binocular indirect ophthalmoscope3,17.
In our investigation over the 10-year period from
1998–2007, the prevalence of ROP lll among examined
newborns with birth weights <1500 g was 18.4%, and the
prevalence among examined newborns with 32 weeks’
gestation was 12.8%; the differences in the prevalences
were not statistically significant. Therefore, we suggest
that examinations for ROP should be performed in all in-
fants with birth weights less than 1500 g, regardless of
their gestational age. There were significantly lower
rates of ROP of stage lll among examined newborns with
birth weights <1500 g (14% vs. 30.6%) and among exam-
ined newborns with 32 weeks’ gestation (8.8% vs. 22.4%)
in Period ll than in Period I.
These results were consistent with those from a study
from the United States, where the prevalence of ROP
with threshold disease was 9.5%8,15. In Canada, the inci-
dence of severe ROP was 48 per 1000 among infants with
mean gestational age of 26 weeks and the mean birth
weight of 750 g18. Various reports revealed that in the
last two decades of the 20th century, the incidence of se-
vere ROP increased because of the improved survival of
extremely low birth weight infants associated with ad-
vances in neonatal intensive care2,19,20.
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TABLE 4
NUMBER OF ROP lll AND TOTAL ROP IN EXAMINED
NEWBORNS WITH  32 WEEKS’ GESTATION IN THE TOTAL






















[ ] – in brackets: number of examined newborns with 32 weeks’
gestation in reviewed period
() – in brackets: percentage of examined newborns with 32 weeks’
gestation in reviewed period
TABLE 5
NUMBER OF LIVEBORN WITH BIRTH WEIGHTS <1500 G OR 32 WEEKS’ GESTATION, NUMBER THAT SURVIVED, NUMBER
EXAMINED AND NUMBER OF ROP III NEWBORNS IN THE ENTIRE REVIEWED PERIOD
1998–2007 Liveborn Survived Examined ROP lll



















* Among all liveborns in reviewed period
** Among all liveborns with birth weights <1500 g/32 weeks’ gestation in the reviewed period
*** Among all surviving newborns with birth weights <1500 g/32 weeks’ gestation in the reviewed period
**** Among all examined newborns with birth weights <1500 g/32 weeks’ gestation with ROP lll in the reviewed period
In our investigation, significantly more infants with
birth weights <1500 g or 32 weeks’ gestation survived,
and significantly more surviving infants were examined
in the years 2003–2007 (Period ll) than in 1998–2002 (Pe-
riod I). However, there was a statistically lower preva-
lence of total ROP among examined newborns with birth
weights <1500 g and among examined newborns with
32 weeks’ gestation (47.8% vs. 23.3%) in the years
2002–2007 than in the years 1998–2002. This could be
explained by the use of surfactants, continuous pulse
oximetry, improvements in nutritional support, the use
of antenatal steroids, and improvements in overall care
in the neonatal intensive care unit at our Department.
Our results support the findings of Bullard et al., who
also found that the incidence of all levels of ROP across
all birth weights decreased in the last decades of the 20th
century21.
In the future, the genetic testing of premature new-
borns for genotypes predictive of a higher risk for ROP
could eventually alert neonatologists to at-risk cases.
Until then, moderate exposure to supplemental oxygen,
the avoidance of repeated variations in hypoxia-hyper-
oxia in premature newborns, and the timely detection
and treatment of serious ROP will help the rate of blind-
ness from ROP to drop even further8,22–25.
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PREVALENCIJA RETINOPATIJE U PRIJEVREMENO PO\ENE DJECE U GEOGRAFSKI
DEFINIRANOJ POPULACIJI HRVATSKE
S A @ E T A K
Cilja rada bio je istra`iti prevalneciju retinopatije prematuriteta (ROP) III stupnja u skupini novoro|en~adi ro|ene
sa <1550 g porodne te`ine i gestacijske dobi (GD) 32 tjedna te usporediti prevalenciju u dva vremenski razl~iita razdo-
blja (1998.–2002. god. i 2003.–2007. god.). Istra`ivanje je sprovedeno u Klinici za ginekologiju i porodni{tvo Klini~kog
bolni~kog centra Rijeka, Hrvatska. Probir na ROP provodio je oftalmolog koriste}i binokularni indirektni oftalmoskop.
Tijekom 10 godi{njeg razdoblja bilo je 28,627 `ivoro|ene novoro|en~adi od toga 136 (0,48%) prematurusa sa porodnom
te`inom <1500 g i 226 (0,79%) novoro|en~adi sa GD 32 tjedna. Omjer pre`ivaljavanja u novoro|en~adi sa porodnom
te`inom <1500 g (51,1% vs.70,5%) i izme|u novoro|en~adi sa GD 32 tjedna bila je zna~ajno vi{a u drugom razdoblju
(2003.–2007. god.). Ve}i broj novoro|ena~di sa porodnom te`inom<1500 g (52,9% vs. 97,1%) i novoro|en~adi sa GD 32
tjedna (46,5% vs. 96,9%) podvrgnuto je probiru na ROP u razdoblju od 2003.–2007. god. Prevalencja III stupnja ROP-a
zna~ajno je bila ni`a u razdoblju od 2003.–2007. god. u usporedbi sa razdobljem 1998.–2002. god. u novoro|ena~di sa
porodnom te`inom <1500 g (30,6% vs. 14,0%) i u novoro|en~adi sa GD 32 tjedna (22,4% vs. 8,8%). Ukupna preva-
lencija ROPa-u skupini novoro|en~adi zna~ajno je bila ni`a u razdoblju 2003.–2007. god. u usporodbi sa razdobljem od
1988.–2002. god. Sni`avanje prevalencije ROP-a mo`e se objasniti napretkom u intezivnom novoro|ena~kom lije~enju,
pove}anju pre`ivaljavanja novoro|en~adi vrlo niske poroden te`ine i sustavnom, vremenski definiranom provo|enju
probira na ROP.
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